Avasimibe (CI-1011, PD-148515) is an orally active acyl coenzyme A-cholesterol acyltransferase (ACAT, also called SOAT)) inhibitor with IC50s of 24 and 9.2 µM for ACAT1 and ACAT2, respectively[1]. Avasimibe can be used for the research of prostate cancer[2].
Molecular Weight:
501.72
Purity:
99.85
CAS Number:
[166518-60-1]
Formula:
C29H43NO4S
Target:
Acyltransferase
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
